Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-30.5%
5Y CAGR+55.2%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-30.5%/yr
Annual compound
5Y CAGR
+55.2%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
9x
Strong expansion
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 22.38% |
| 2024 | 19.05% |
| 2023 | -5.88% |
| 2022 | 66.74% |
| 2021 | 90.44% |
| 2020 | 2.48% |
| 2019 | 28.54% |
| 2018 | -15.33% |
| 2017 | 98.82% |
| 2016 | 43.86% |